Vous êtes ici : Version françaisePublications

Publications 2018

1.    ROUET F, NOUHIN J, ZHENG DP, ROCHE B, BLACK A, PRAK S, LEOZ M, GAUDY-GRAFFIN C, FERRADINI L, MOM C, MAM S, GAUTIER C, LESAGE G, KEN S, PHON K, KERLEGUER A, YANG C, KILLAM W, FUJITA M, MEAN C, FONTENILLE D, BARIN F, PLANTIER JC, BEDFORD T, RAMOS A, SAPHONN V. Massive Iatrogenic Outbreak of Human Immunodeficiency Virus Type 1 in Rural Cambodia, 2014-2015. Clin Infect Dis 2018, 66: 1733-1741.

2.    BONNAFOUS P, MARLET J, BOUVET D, SALAME E, TELLIER AC, GUYETANT S, GOUDEAU A, AGUT H, GAUTHERET-DEJEAN A, GAUDY-GRAFFIN C. Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation. Am J Transplant 2018, 18: 1548-1551.

3.    BENDENOUN M, SAMRI A, AVETTAND-FÈNOËL V, CARDINAUD S, DESCOURS B, CARCELAIN G, MAZERON MC, BERGMANN JF, URRUTIA A, MORIS A, ROUZIOUX C, SIMON F, ANDRE P, POCARD M, DRAY X, MOUREZ T, VIEILLARD V, AUTRAN B, BARIN F, SELLIER P. What is the most important for elite control: genetic background of patient, genetic background of partner, both or neither? Description of complete natural history within a couple of MSM. Ebio Medicine 2018, 27:51-60.

4.    STEFFIC K, NOVELLI S, MAHJOUB N, SENG R, MOLINA J-M, CHENEAU C, BARIN F, CHAIX M-L, MEYER L, DELAUGERRE C. Non-reactive rapid tests afer sustained viral supression following antiretroviral therapy initiation during primary infection. J Infect Dis 2018, 217: 1793-1797.

5.    EL MESHRI S, BOUTANT E, MOUHAND A, THOMAS A, LARUE V, RICHERT L, VIVET-BOUDOU V, MELY Y, TISNE C, MURIAUX D, DE ROCQUIGNY H. The NC domain of HIV-1 Gag contributes to the interaction of GAG with TSG101. Biochim Biophys Acta Gen Subj 2018, 1862: 1421-1431.

6.    DEJARNAC O, HAFIRASSOU ML, CHAZAL M, VERSAPUECH M, GAILLARD J, PERERA-LECOIN M, UMANA-DIAZ C, BONNET-MADIN L, CARNER C, TIVENEZ J-Y, DELAUGERRE C, SCHWARTZ O, ROINGEARD P, JOUVENET N, BERLIOZ-TORRENT C,  MEERTENS L, AMARA A. TIM-1 is a dengue virus bona fide entry receptor. Cell Report 2018, 23 : 1779-1793.

7.    SOMMEN C, SABONI L, SAUVAGE C, ALEXANDRE A, LOT F, BARIN F, VELTER A. Time location sampling in men who have sex with men in the HIV context: the importance of taking into account sampling weights and frequency of venue attendance. Epidemiol Infect 2018, 146, 913-919.

8.    MARLET J, GAUDY-GRAFFIN C, MARC D, BOENNEC R, GOUDEAU A. Factors associated with influenza vaccination failure and severe disease in a French region in 2015. PLoS One 2018, 13: e0195611.

9.    PARIS J, TOBALY-TAPIERO J, GIRON M-L, BURLAUD-GAILLARD J, BUSEYNE F, ROINGEARD P,    LESAGE P, ZAMBORLINI A, SAÏB A. The invariant arginine within the chromatin-binding motif regulates both nucleolar localization and chromatin binding of Foamy virus Gag. Retrovirology 2018 ; 15 : 48.

10.     PHAM V, SALGUERO C, KHAN S, MEAGHER J, BROWN W, HUMBERT N, DE ROCQUIGNY H, SMITH JL, DA SOUZA VM. HIV-1 Tat interactions with cellular 7SK and viral TAR RNAs identifies dual structural mimicry. Nat Commun 2018 ; 9 : 4266.

11.    FLODERER C, MASSON J-B, BOILLEY E, GEORGEAULT S, MERIDA P, EL BEHEIRY M, DAHAN M, ROINGEARD P, SIBATIRA J-B, FAVARD C, MURIAUX D. Multiplexing single molecule localization and energy mapping reveal how the viral RNA coordinates HIV-1 Gag assembly in CD4 cells. Sci Rep 2018 ; 8 : 16283.

12.    LYDIÉ N, SABONI L, GAUTIER A, BROUARD C, CHEVALIEZ S, BARIN F, LARSEN C, LOT F, RAHIB D. Innovative Approach for Enhancing Testing of HIV, Hepatitis B, and Hepatitis C in the General Population: Protocol for an Acceptability and Feasibility Study (BaroTest 2016). JMIR Res Protoc 2018 ; 7 :e180.

13.    BLANCHARD E, ROINGEARD P.The hepatitis C virus-induced membranous web in liver tissue proteins for viral assembly. Cells 2018, 7 : 11.

14.    GATAULT P, AL-HAJJ S, NOBLE J, CHEVALLIER E, PIOLLET M, FORCONI C, GAUDY-GRAFFIN C, THIBAULT G, MIQUELESTORENA-STANDLEY E, HALIMI JM, BÜCHLER M, LEMOINE R, BARON C. CMV-infected kidney grafts drive the expansion of blood-borne CMV-specific T cells restricted by shared class I HLA molecules via presentation on donor cells. Am J Transplant 2018, in press

15.    BERETTA M, MOREAU A, BOUVIN-PLEY M, ESSAT A, GOUJARD C, CHAIX M-L, HUE S, MEYER L, BARIN F, BRAIBANT M, ON BEHALF OF THE ANRS 06 PRIMO COHORT. Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains. AIDS 2018, in press

16.     BONNAFOUS P, MARLET J, GAUDY-GRAFFIN C, GAUTHERET-DEJEAN A. Need for a better characterization of HHV-6 infections and associated clinical impacts. Am J Transplant 2018, in press

17.    ROINGEARD P, RAYNAL P-I, EYMIEUX S, BLANCHARD E. Virus detection by transmission electron microscopy: still useful for diagnosis and a plus for biosafety. Rev Med Virol 2018, in press

18.    APPOURCHAUX R, DELPEUCH M, ZHONG LI, BURLAUD-GAILLARD J, TARTOUR K, SAVIDIS G, BRASS A, ETIENNE L, ROINGEARD P, CIMARELLI A.  Functional mapping of regions involved in the negative imprinting of virion particles infectivity and in target cell protection by the interferon-induced transmembrane protein 3 (IFITM3) against HIV-1 : evidence in favour of a single antiviral mechanism. J Virol 2018, in press

19.     STEFIC K, BOUVIN-PLEY M, ESSAT A, VISDELOUP C, MOREAU A, GOUJARD C, CHAIX ML, BRAIBANT M, MEYER L, BARIN F. Sensitivity to broadly neutralizing antibodies of recently transmitted HIV-1 clade CRF02_AG viruses with a focus on evolution over time. J Virol. 2018, in press

20.    BOUVIN-PLEY M, BERETTA M, MOREAU A, ROCH E, ESSAT A, GOUJARD C, CHAIX ML, MOIRÉ N, MARTIN L, MEYER L, BARIN F, BRAIBANT M. Evolution of the envelope glycoprotein of HIV-1 clade B towards higher infectious properties over the course of the epidemic. J Virol 2018, in press

21.    TODESCO E, WIRDEN M, CALIN R, SIMON A, SAYON S, BARIN F, KATLAMA C, CALVEZ V, MARCELIN AG, HUÉ S. Caution is needed in interpreting HIV transmission chains by ultra-deep sequencing. AIDS 2018, in press